Condition
Infertility
Infertility is difficulty conceiving that can stem from sperm, eggs, or both, and both depend on mitochondrial energy that fades with age and oxidative stress. Folic acid has the most support, with moderate evidence that sperm motility improved, while smaller trials found antioxidant enzymes went up in semen with coenzyme Q10 and DNA damage improved with L-carnitine. Those studies were small, and the findings mostly concern men rather than egg quality in women.
Sources: PMID 37539255; PMID 23289958
- Supplements studied
- 23
- Medicines and peptides
- 3
- Graded outcomes
- 35
- Trials
- 34
- People studied
- 12,966
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Estrogen Small Increase | Worsens (the measure goes up) | Small effect | 1 study | 76 people | ||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 3 studies | 76 people | |||
Studies that measured follicle-stimulating hormone
| ||||||
| Sperm Count | Improves (the measure goes up) | 1 study | 135 people | |||
Studies that measured sperm count | ||||||
| Testosterone | Improves (the measure goes up) | 1 study | 76 people | |||
Studies that measured testosterone | ||||||
| Luteinizing Hormone | Improves (the measure goes up) | 76 people | ||||
| Prolactin | Improves (the measure goes up) | 56 people | ||||
| Serum T4 | Improves (the measure goes up) | 20 people | ||||
| Sperm Quality | Improves (the measure goes up) | 20 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 20 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seminal Motility Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 326 people | ||
| Sperm Count | Improves (the measure goes up) | 2,168 people | ||||
Saffron
- Blood Pressure: improves
- Seminal Motility: improves
- Hemoglobin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 230 people | ||
Studies that measured blood pressure
| ||||||
| Seminal Motility | Improves (the measure goes up) | 2 studies | 282 people | |||
Studies that measured seminal motility | ||||||
| Hemoglobin | Improves (the measure goes up) | 1 study | 230 people | |||
Studies that measured hemoglobin | ||||||
| Sperm Count | Improves (the measure goes up) | 1 study | 282 people | |||
| Ejaculate Volume | Improves (the measure goes up) | 230 people | ||||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 230 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 230 people | ||||
| Prolactin | Improves (the measure goes up) | 230 people | ||||
| Sperm Quality | Improves (the measure goes up) | 282 people | ||||
| Testosterone | Improves (the measure goes up) | 230 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 230 people | ||||
Inositol
- Fertility: improves
- Oocyte Quality: improves
- Oocyte Quantity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fertility Small Improvement | Improves (the measure goes up) | Small effect | 3 studies | 184 people | ||
Studies that measured fertility
| ||||||
| Oocyte Quality | Improves (the measure goes up) | 84 people | ||||
| Oocyte Quantity | Improves (the measure goes up) | 100 people | ||||
| PCOS Symptoms | Improves (the measure goes down) | 184 people | ||||
Coenzyme Q10
- Anti-Oxidant Enzyme Profile: improves
- Oxidative Stress Biomarkers: improves
- Follicle-Stimulating Hormone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 2 studies | 60 people | ||
Studies that measured anti-oxidant enzyme profile | ||||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 9 studies | 107 people | |||
Studies that measured oxidative stress biomarkers
| ||||||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 2 studies | 212 people | |||
| Seminal Motility | Improves (the measure goes up) | 2 studies | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 212 people | ||||
| Sperm Count | Improves (the measure goes up) | |||||
| Sperm Quality | Improves (the measure goes up) | 341 people | ||||
| Testosterone | Improves (the measure goes up) | 212 people | ||||
Ashwagandha
- Cortisol: improves
- Testosterone: improves
- Sperm Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cortisol Moderate Decrease | Improves (the measure goes down) | Moderate effect | 1 study | 60 people | ||
| Testosterone | Improves (the measure goes up) | 5 studies | 361 people | |||
Studies that measured testosterone
| ||||||
| Sperm Quality | Improves (the measure goes up) | 1 study | 401 people | |||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 135 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 181 people | ||||
| Seminal Motility | Improves (the measure goes up) | 286 people | ||||
| Sperm Count | Improves (the measure goes up) | 206 people | ||||
Zinc
- Seminal Motility: improves
- Sperm Count: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seminal Motility Small Improvement | Improves (the measure goes up) | Small effect | 2,168 people | |||
| Sperm Count | Improves (the measure goes up) | 2,168 people |
Vitamin C
- Seminal Motility: improves
- Sperm Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seminal Motility Moderate Improvement | Improves (the measure goes up) | Moderate effect | 120 people | |||
| Sperm Quality | Improves (the measure goes up) | 1 study | 120 people | |||
Studies that measured sperm quality | ||||||
Shilajit
- Follicle-Stimulating Hormone: improves
- Luteinizing Hormone
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Follicle-Stimulating Hormone Small Increase | Improves (the measure goes up) | Small effect | 60 people | |||
| Luteinizing Hormone No effect | NoneNo effect | 60 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 60 people | |||
Studies that measured oxidative stress biomarkers | ||||||
| Sperm Quality | Improves (the measure goes up) | 60 people | ||||
| Testosterone | Improves (the measure goes up) | 60 people | ||||
Cangfu Daotan Decoction
- Ovulation Rate: improves
- Pregnancy Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Ovulation Rate Meta-analyses of Chinese RCTs: CFDTD + clomiphene improved ovulation rates vs clomiphene alone in PCOS patients. Evidence quality is low due to methodological limitations. | Improves (the measure goes up) | Moderate effect | 1,200 people | |||
| Pregnancy Rate Meta-analysis: Higher pregnancy rates when CFDTD added to clomiphene treatment for PCOS-related infertility. Studies have high heterogeneity and risk of bias. | Improves (the measure goes up) | Moderate effect | 900 people |
Berberine
- Blood glucose: improves
- Total cholesterol: improves
- Body Mass Index (BMI): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Large Improvement | Improves (the measure goes down) | Large effect | 1,544 people | |||
| Total cholesterol | Improves (the measure goes down) | 3 studies | 457 people | |||
Studies that measured total cholesterol
| ||||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 1 study | 487 people | |||
Studies that measured body mass index (bmi) | ||||||
| Fertility | Improves (the measure goes up) | 501 people | ||||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 497 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 577 people | ||||
| Sex Hormone Binding Globulin | Improves (the measure goes up) | 228 people | ||||
| Testosterone | Improves (the measure goes up) | 577 people | ||||
| Waist-Hip Ratio | Improves (the measure goes up) | 402 people | ||||
L-Carnitine
- DNA Damage: improves
- Sperm Quality: improves
- Seminal Motility: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| DNA Damage Small Improvement | Improves (the measure goes down) | Small effect | 100 people | |||
| Sperm Quality | Improves (the measure goes up) | 10 studies | ||||
Studies that measured sperm quality
| ||||||
| Seminal Motility | Improves (the measure goes up) | 1 study | ||||
Studies that measured seminal motility | ||||||
| Fertility | Improves (the measure goes up) | 338 people | ||||
| Sperm Count | Improves (the measure goes up) | |||||
Aspartate
- Sperm Motility: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Sperm Motility 2660mg DAA + ubiquinol + zinc improved progressive sperm motility and testosterone (p=0.009) over 3 months | Improves (the measure goes up) | Moderate effect | 90 people |
Ginger (Zingiber officinale)
- Anti-Oxidant Enzyme Profile: improves
- Ejaculate Volume: improves
- Follicle-Stimulating Hormone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 75 people | |||
| Ejaculate Volume | Improves (the measure goes up) | 75 people | ||||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 75 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 75 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 75 people | ||||
| Seminal Motility | Improves (the measure goes up) | 75 people | ||||
| Sperm Count | Improves (the measure goes up) | 75 people | ||||
| Sperm Quality | Improves (the measure goes up) | 75 people | ||||
| Testosterone | Improves (the measure goes up) | 75 people |
Tribulus Terrestris
- Body Fat
- Erections: improves
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat No effect | NoneNo effect | 2 studies | 65 people | |||
| Erections | Improves (the measure goes up) | 4 studies | 63 people | |||
| Testosterone | Improves (the measure goes up) | 3 studies | 93 people | |||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 1 study | 65 people | |||
| Sperm Count | Improves (the measure goes up) | 1 study | 158 people | |||
| DHT | Improves (the measure goes up) | 65 people | ||||
| Fatigue Symptoms | Improves (the measure goes down) | 63 people | ||||
| Free Testosterone | Improves (the measure goes up) | 95 people | ||||
| Libido | Improves (the measure goes up) | 63 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 95 people | ||||
| Muscle Mass | Improves (the measure goes up) | 65 people | ||||
| Prolactin | Improves (the measure goes up) | 65 people | ||||
| Seminal Motility | Improves (the measure goes up) | 65 people | ||||
| Serum DHEA | Improves (the measure goes up) | 65 people | ||||
| Sperm Quality | Improves (the measure goes up) | 93 people |
Vitamin D
- Seminal Motility
- Sperm Count: improves
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seminal Motility No effect | NoneNo effect | |||||
| Sperm Count | Improves (the measure goes up) | 1 study | ||||
| Testosterone | Improves (the measure goes up) | 1 study | 449 people | |||
| Sex Hormone Binding Globulin | Improves (the measure goes up) | 449 people | ||||
| Sperm Quality | Improves (the measure goes up) |
Vitamin E
- Seminal Motility
- Sperm Count: improves
- Sperm Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seminal Motility No effect | NoneNo effect | |||||
| Sperm Count | Improves (the measure goes up) | |||||
| Sperm Quality | Improves (the measure goes up) |
Alpha-Lipoic Acid
- Seminal Motility
- Sperm Count: improves
- Sperm Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seminal Motility No effect on sperm motility | NoneNo effect | 60 people | ||||
| Sperm Count | Improves (the measure goes up) | 2 studies | ||||
| Sperm Quality | Improves (the measure goes up) |
Spirulina
- Sperm Count
- Sperm Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Sperm Count No effect | NoneNo effect | 49 people | ||||
| Sperm Quality | Improves (the measure goes up) | 1 study | 49 people |
Omega-3 Fatty Acids
- Seminal Motility
- Sperm Count: improves
- Sperm Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seminal Motility No effect | NoneNo effect | |||||
| Sperm Count | Improves (the measure goes up) | |||||
| Sperm Quality | Improves (the measure goes up) |
Astaxanthin
- Ejaculate Volume
- Oxidative Stress Biomarkers: changes; see studies
- Fertility: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Ejaculate Volume No effect | NoneNo effect | 30 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 3 studies | 143 people | |||
| Fertility | Improves (the measure goes up) | 1 study | 30 people | |||
| Oocyte Quantity | Improves (the measure goes up) | 1 study | 143 people | |||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 30 people | ||||
| Inhibin B | Improves (the measure goes up) | 30 people | ||||
| Oocyte Quality | Improves (the measure goes up) | 143 people | ||||
| Seminal Motility | Improves (the measure goes up) | 30 people | ||||
| Sperm Count | Improves (the measure goes up) | 30 people | ||||
| Sperm Quality | Improves (the measure goes up) | 30 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 143 people | ||||
| Testosterone | Improves (the measure goes up) | 30 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 143 people |
DHEA
- Fertility: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fertility | Improves (the measure goes up) | 1 study | 33 people |
Panax Ginseng (Korean Ginseng)
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Testosterone | Improves (the measure goes up) | 1 study | 66 people |
Prescription medicines and peptides studied, for context
Cetrorelix (Cetrotide)
- LH Surge Prevention: improves
- Clinical Pregnancy Rate: improves
- OHSS Prevention: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| LH Surge Prevention ~100% prevention of premature LH surge across multiple RCTs. Single 3mg dose or daily 0.25mg both effective. Gold standard for IVF protocols. | Improves (the measure goes down) | Large effect | 170 studies | |||
| Clinical Pregnancy Rate Phase 2/3 trials: 184 pregnancies from 732 patients (25.1%). Comparable to or better than GnRH agonist protocols. | Improves (the measure goes up) | Moderate effect | 167 studies | |||
| OHSS Prevention Nearly 100% prevention of ovarian hyperstimulation syndrome. Major safety advantage over GnRH agonist protocols. | Changes; see studies | Large effect | 164 studies | |||
| Follicle Development Allows controlled ovarian stimulation without interference. Fewer injections required vs ganirelix in flexible protocols. | Improves (the measure goes up) | Moderate effect | 164 studies |
Kisspeptin-54
- Ovarian Hyperstimulation Syndrome Prevention: improves
- Oocyte Maturation (IVF): improves
- Egg Maturation Trigger: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Ovarian Hyperstimulation Syndrome Prevention Only 7% of kisspeptin-treated women developed mild OHSS, with no moderate, severe, or critical cases - a significant improvement over standard hCG triggers in high-risk patients. | Improves (the measure goes up) | Large effect | 16 studies | |||
| Oocyte Maturation (IVF) Phase 2 clinical trial showed kisspeptin-54 effectively triggered oocyte maturation in 95% of women at high risk of OHSS, with embryo formation in 90%. | Improves (the measure goes up) | Large effect | 15 studies | |||
| Egg Maturation Trigger Kisspeptin-54 successfully triggers egg maturation sufficient for fertilization, embryo implantation, and live birth in IVF patients. | Improves (the measure goes up) | Large effect | 14 studies | |||
| IVF Pregnancy Rate A single injection of kisspeptin-54 resulted in mature eggs successfully fertilized and transferred, with pregnancy achieved in 23% of subfertile patients undergoing IVF. | Improves (the measure goes up) | Moderate effect | 14 studies |
Ganirelix (Antagon/Orgalutran)
- LH Surge Prevention: improves
- Pregnancy Rate: improves
- OHSS Prevention: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| LH Surge Prevention Phase III: 0.25mg is minimal effective dose for LH surge prevention. Comparable efficacy to leuprolide and triptorelin protocols. | Improves (the measure goes down) | Large effect | 11 studies | |||
| Pregnancy Rate Ongoing pregnancy rate 31.0% (ganirelix) vs 33.9% (triptorelin). Implantation rate identical at 22.9%. Comparable to GnRH agonist protocols. | Improves (the measure goes up) | Moderate effect | 10 studies | |||
| OHSS Prevention 2.4% OHSS incidence vs 5.9% with buserelin. Preferred protocol for high responders and oocyte donors. | Changes; see studies | Moderate effect | 9 studies | |||
| Treatment Duration 5 days treatment vs 26 days with buserelin. Fewer injections required. Enhanced patient convenience and compliance. | Improves (the measure goes down) | Large effect | 9 studies |
Key findings
- EstrogenWorsens (the measure goes up)
- Seminal MotilityImproves (the measure goes up)
- Blood PressureImproves (the measure goes down)
Safety notes in the studies
- Studies have high heterogeneity and risk of bias.
- Only 7% of kisspeptin-treated women developed mild OHSS, with no moderate, severe, or critical cases - a significant improvement over standard hCG triggers in high-risk patients.
- Phase 2 clinical trial showed kisspeptin-54 effectively triggered oocyte maturation in 95% of women at high risk of OHSS, with embryo formation in 90%.
The Infertility (Male & Female) protocol
2 primary supplements · 2 supporting supplements
- Coenzyme Q10200–600 mg daily
- L-Carnitine2–3 g daily (as L-carnitine or acetyl-L-carnitine)
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplements graded A or B for Infertility. Each opens third-party tested products for that supplement.
- Grade B
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
1 study from PubMed